Taking care of patients and their families is my most important job.

MEDICAL SERVICES

EDUCATION

Undergraduate Degree

  • Brown University , 2003 , Providence , RI

Medical School

  • Yale University School of Medicine , 2007 , New Haven , CT

Residency

  • Boston Combined Residency Program (BCRP) , 2009 , Boston , MA

Residency

Neurology
  • Boston Children's Hospital , 2012 , Boston , MA

Fellowship

Behavioral Neurology
  • Boston Children's Hospital , 2014 , Boston , MA

Fellowship

Postdoctoral Research
  • Boston Children's Hospital , 2014 , Boston , MA

Philosophy of Care

Taking care of patients and their families is my most important job.  Children and families facing autism often have a lot of questions. They need to know about therapies, education, and medical problems that sometimes go along with autism.  They need to know about coping with their child’s diagnosis and building a supportive community.  There’s still a lot that is unknown about autism, however, which means that families often come to my office with questions that don’t have an answer yet.  That’s why I do research.  I want to find answers to those unanswered questions.

PROFESSIONAL HISTORY

I am currently an instructor and attending physician in neurology.  My clinical work and research focus on management of autism from a child neurology perspective.
 

In the neurology clinic, my focus is on caring for children with autism.  In addition to seeing patients, I am working to implement an online parent questionnaire that will help families and clinicians monitor outcomes over time in children with autism.

My primary research focuses on identifying biomarkers of autism, using information about brain rhythms as measured by EEG.  The long-term goal of this research is to find new ways to predict, diagnose, and monitor autism; in the process, I hope to shed light on how the brain works in children with autism. 

I am also involved with the Bucharest Early Intervention Project, which examines the effects of institutionalization versus foster care on child development.  Alongside my participation in this research project, I have been involved in clinical, teaching, and volunteer work in Romanian hospitals and orphanages since 1999.

In summary, my interests remain focused on evaluating and treating autism and related neurodevelopmental disorders, from a neurological perspective.

CERTIFICATIONS

  • American Board of Psychiatry and Neurology, Child and Adolescent Neurology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. van Noordt S, Desjardins JA, Huberty S, Abou-Abbas L, Webb SJ, Levin AR, Segalowitz SJ, Evans AC, Elsabbagh M. EEG-IP: an international infant EEG data integration platform for the study of risk and resilience in autism and related conditions. Mol Med. 2020 May 07; 26(1):40. View abstract
  2. Levin AR, Naples AJ, Scheffler AW, Webb SJ, Shic F, Sugar CA, Murias M, Bernier RA, Chawarska K, Dawson G, Faja S, Jeste S, Nelson CA, McPartland JC, Sentürk D. Day-to-Day Test-Retest Reliability of EEG Profiles in Children With Autism Spectrum Disorder and Typical Development. Front Integr Neurosci. 2020; 14:21. View abstract
  3. McPartland JC, Bernier RA, Jeste SS, Dawson G, Nelson CA, Chawarska K, Earl R, Faja S, Johnson SP, Sikich L, Brandt CA, Dziura JD, Rozenblit L, Hellemann G, Levin AR, Murias M, Naples AJ, Platt ML, Sabatos-DeVito M, Shic F, Senturk D, Sugar CA, Webb SJ. The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification. Front Integr Neurosci. 2020; 14:16. View abstract
  4. Webb SJ, Shic F, Murias M, Sugar CA, Naples AJ, Barney E, Borland H, Hellemann G, Johnson S, Kim M, Levin AR, Sabatos-DeVito M, Santhosh M, Senturk D, Dziura J, Bernier RA, Chawarska K, Dawson G, Faja S, Jeste S, McPartland J and the Autism Biomarkers Consortium for Clinical Trials. Biomarker Acquisition and Quality Control for Multisite Studies: The Autism Biomarkers Consortium for Clinical Trials. Front Integr Neurosci. 2020; 13(71). View abstract
  5. Webb SJ, Shic F, Murias M, Sugar CA, Naples AJ, Barney E, Borland H, Hellemann G, Johnson S, Kim M, Levin AR, Sabatos-DeVito M, Santhosh M, Senturk D, Dziura J, Bernier RA, Chawarska K, Dawson G, Faja S, Jeste S, McPartland J. Biomarker Acquisition and Quality Control for Multi-Site Studies: The Autism Biomarkers Consortium for Clinical Trials. Front Integr Neurosci. 2019; 13:71. View abstract
  6. Gabard-Durnam LJ, Wilkinson C, Kapur K, Tager-Flusberg H, Levin AR, Nelson CA. Longitudinal EEG power in the first postnatal year differentiates autism outcomes. Nat Commun. 2019 09 13; 10(1):4188. View abstract
  7. Roche KJ, LeBlanc JJ, Levin AR, O'Leary HM, Baczewski LM, Nelson CA. Electroencephalographic spectral power as a marker of cortical function and disease severity in girls with Rett syndrome. J Neurodev Disord. 2019 07 31; 11(1):15. View abstract
  8. Wilkinson CL, Levin AR, Gabard-Durnam LJ, Tager-Flusberg H, Nelson CA. Reduced frontal gamma power at 24 months is associated with better expressive language in toddlers at risk for autism. Autism Res. 2019 08; 12(8):1211-1224. View abstract
  9. Iverson JM, Shic F, Wall CA, Chawarska K, Curtin S, Estes A, Gardner JM, Hutman T, Landa RJ, Levin AR, Libertus K, Messinger DS, Nelson CA, Ozonoff S, Sacrey LR, Sheperd K, Stone WL, Tager-Flusberg HB, Wolff JJ, Yirmiya N, Young GS. Early motor abilities in infants at heightened versus low risk for ASD: A Baby Siblings Research Consortium (BSRC) study. J Abnorm Psychol. 2019 Jan; 128(1):69-80. View abstract
  10. Sahin M, Jones SR, Sweeney JA, Berry-Kravis E, Connors BW, Ewen JB, Hartman AL, Levin AR, Potter WZ, Mamounas LA. Discovering translational biomarkers in neurodevelopmental disorders. Nat Rev Drug Discov. 2018 Dec 20. View abstract
  11. Levin AR, Méndez Leal AS, Gabard-Durnam LJ, O'Leary HM. BEAPP: The Batch Electroencephalography Automated Processing Platform. Front Neurosci. 2018; 12:513. View abstract
  12. Gabard-Durnam LJ, Mendez Leal AS, Wilkinson CL, Levin AR. The Harvard Automated Processing Pipeline for Electroencephalography (HAPPE): Standardized Processing Software for Developmental and High-Artifact Data. Front Neurosci. 2018; 12:97. View abstract
  13. Levin AR, Varcin KJ, O'Leary HM, Tager-Flusberg H, Nelson CA. EEG power at 3 months in infants at high familial risk for autism. J Neurodev Disord. 2017 Sep 13; 9(1):34. View abstract
  14. Levin AR, Nelson CA. Inhibition-Based Biomarkers for Autism Spectrum Disorder. Neurotherapeutics. 2015 Jul; 12(3):546-52. View abstract
  15. Stein DS, Welchons LW, Corley KB, Dickinson H, Levin AR, Nelson CA, Stein MT. Autism associated with early institutionalization, high intelligence, and naturalistic behavior therapy in a 7-year-old boy. J Dev Behav Pediatr. 2015 Jan; 36(1):53-5. View abstract
  16. Levin AR, Fox NA, Zeanah CH, Nelson CA. Social communication difficulties and autism in previously institutionalized children. J Am Acad Child Adolesc Psychiatry. 2015 Feb; 54(2):108-15.e1. View abstract
  17. Levin AR, Zeanah CH, Fox NA, Nelson CA. Motor outcomes in children exposed to early psychosocial deprivation. J Pediatr. 2014 Jan; 164(1):123-129.e1. View abstract
  18. Varghese GI, Purcaro MJ, Motelow JE, Enev M, McNally KA, Levin AR, Hirsch LJ, Tikofsky R, Paige AL, Zubal IG, Spencer SS, Blumenfeld H. Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures. Brain. 2009 Aug; 132(Pt 8):2102-13. View abstract
  19. Blumenfeld H, Varghese GI, Purcaro MJ, Motelow JE, Enev M, McNally KA, Levin AR, Hirsch LJ, Tikofsky R, Zubal IG, Paige AL, Spencer SS. Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures. Brain. 2009 Apr; 132(Pt 4):999-1012. View abstract
  20. Blumenfeld H, Klein JP, Schridde U, Vestal M, Rice T, Khera DS, Bashyal C, Giblin K, Paul-Laughinghouse C, Wang F, Phadke A, Mission J, Agarwal RK, Englot DJ, Motelow J, Nersesyan H, Waxman SG, Levin AR. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia. 2008 Mar; 49(3):400-9. View abstract
  21. Harrington JF, Messier AA, Levine A, Szmydynger-Chodobska J, Chodobski A. Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma. 2005 Aug; 22(8):919-28. View abstract
  22. Goldie SJ, Levin AR. msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis. JAMA. 2001 Oct 03; 286(13):1637-8. View abstract